NM_001205293.3:c.5680-46C>T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001205293.3(CACNA1E):​c.5680-46C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.197 in 1,281,290 control chromosomes in the GnomAD database, including 26,416 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.20 ( 3205 hom., cov: 32)
Exomes 𝑓: 0.20 ( 23211 hom. )

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.444

Publications

14 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-181785667-C-T is Benign according to our data. Variant chr1-181785667-C-T is described in ClinVar as Benign. ClinVar VariationId is 1262703.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.286 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001205293.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
NM_001205293.3
MANE Select
c.5680-46C>T
intron
N/ANP_001192222.1
CACNA1E
NM_000721.4
c.5680-46C>T
intron
N/ANP_000712.2
CACNA1E
NM_001205294.2
c.5623-46C>T
intron
N/ANP_001192223.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CACNA1E
ENST00000367573.7
TSL:1 MANE Select
c.5680-46C>T
intron
N/AENSP00000356545.2
CACNA1E
ENST00000360108.7
TSL:5
c.5623-46C>T
intron
N/AENSP00000353222.3
CACNA1E
ENST00000367570.6
TSL:1
c.5680-46C>T
intron
N/AENSP00000356542.1

Frequencies

GnomAD3 genomes
AF:
0.204
AC:
31021
AN:
152028
Hom.:
3201
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.224
Gnomad AMI
AF:
0.325
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.173
Gnomad EAS
AF:
0.246
Gnomad SAS
AF:
0.300
Gnomad FIN
AF:
0.199
Gnomad MID
AF:
0.266
Gnomad NFE
AF:
0.188
Gnomad OTH
AF:
0.219
GnomAD2 exomes
AF:
0.210
AC:
51448
AN:
245516
AF XY:
0.215
show subpopulations
Gnomad AFR exome
AF:
0.228
Gnomad AMR exome
AF:
0.163
Gnomad ASJ exome
AF:
0.180
Gnomad EAS exome
AF:
0.273
Gnomad FIN exome
AF:
0.206
Gnomad NFE exome
AF:
0.189
Gnomad OTH exome
AF:
0.185
GnomAD4 exome
AF:
0.197
AC:
221994
AN:
1129144
Hom.:
23211
Cov.:
15
AF XY:
0.201
AC XY:
115945
AN XY:
577752
show subpopulations
African (AFR)
AF:
0.214
AC:
5734
AN:
26776
American (AMR)
AF:
0.163
AC:
7067
AN:
43284
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
4241
AN:
24108
East Asian (EAS)
AF:
0.236
AC:
9000
AN:
38118
South Asian (SAS)
AF:
0.303
AC:
23888
AN:
78838
European-Finnish (FIN)
AF:
0.200
AC:
10640
AN:
53232
Middle Eastern (MID)
AF:
0.265
AC:
1369
AN:
5166
European-Non Finnish (NFE)
AF:
0.185
AC:
150005
AN:
810126
Other (OTH)
AF:
0.203
AC:
10050
AN:
49496
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
10116
20232
30348
40464
50580
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4550
9100
13650
18200
22750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.204
AC:
31026
AN:
152146
Hom.:
3205
Cov.:
32
AF XY:
0.207
AC XY:
15396
AN XY:
74392
show subpopulations
African (AFR)
AF:
0.224
AC:
9291
AN:
41476
American (AMR)
AF:
0.177
AC:
2701
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.173
AC:
602
AN:
3472
East Asian (EAS)
AF:
0.246
AC:
1271
AN:
5172
South Asian (SAS)
AF:
0.299
AC:
1444
AN:
4826
European-Finnish (FIN)
AF:
0.199
AC:
2112
AN:
10598
Middle Eastern (MID)
AF:
0.245
AC:
72
AN:
294
European-Non Finnish (NFE)
AF:
0.188
AC:
12775
AN:
67992
Other (OTH)
AF:
0.219
AC:
462
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1280
2560
3839
5119
6399
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.189
Hom.:
11998
Bravo
AF:
0.202
Asia WGS
AF:
0.251
AC:
870
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Mar 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.7
DANN
Benign
0.67
PhyloP100
-0.44
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs473200; hg19: chr1-181754803; COSMIC: COSV62382745; COSMIC: COSV62382745; API